WSC 2023

Lys Therapeutics announces to attend the 15th World Stroke Organization Congress (#WSC2023, 10-12 October 2023) happening right now in #Toronto, Canada.

Lys Therapeutics and Institut BB@C – Blood and Brain @ Caen normandie are proud to be presenting during this international conference new groundbreaking preclinical data using Lys Therapeutics’s monoclonal antibody in ischemic #stroke in combination with #alteplase or #tenecteplase, including in an extended therapeutic window.

Presentation: “Glunomab: a monoclonal antibody counteracting blood-brain barrier disruption induced both by endogenous tPA and fibrinolytic agents (alteplase or tenecteplase) after ischemic stroke”.

Dr. Manuel BLANC, CEO, is happy to meet you there.

đź’Ş All together against Stroke and its dramatic consequences.

———-
#WSC2023 #WSO #Stroke #neurosciences #clinicaltrials #Research #rtpa #TNK #biotech #healthcare #lifesciences #CNS #NeurologicalDiseases #NeurovascularDisorders #innovation #MedicalNeeds #LysTherapeutics #NeuroImmunology #Glunomab #GlunozumabProgram

With the World Stroke Organization, Boehringer Ingelheim, Roche, Inserm, Université de Caen, CYCERON, ADNormandie, Lyonbiopôle and Bpifrance.